Preventing opioid overdoses among college students
Opioid overdose prevention in US higher education settings: a multisite, mixed methods study of college students and institutional leaders
This study is looking into the increasing number of opioid overdoses among college students, especially due to fentanyl, and it wants to find out how ready students and college leaders are to handle these situations so that better prevention strategies can be created to keep everyone safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10947526 on NIH RePORTER |
What this research studies
This research investigates the rising rates of opioid overdoses among college students, particularly focusing on the impact of fentanyl. It aims to gather large-scale data on how prepared college students are for opioid overdoses and to understand the perspectives of college leaders on overdose prevention. By employing mixed methods, the study will analyze both quantitative data and qualitative insights to develop effective prevention strategies tailored for this vulnerable population. The findings could help shape policies and interventions that enhance overdose preparedness in higher education settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include college students aged 18-25 who may be at risk for opioid misuse or overdose.
Not a fit: Patients who are not enrolled in college or who are outside the age range of 18-25 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing opioid overdoses among college students, potentially saving lives.
How similar studies have performed: Other research has shown success in implementing overdose prevention programs in educational settings, indicating that this approach has potential for effectiveness.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Freibott, Christina Elliott — Boston University Medical Campus
- Study coordinator: Freibott, Christina Elliott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.